alborixin has been researched along with maduramicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blagburn, BL; Hall, JE; Lindsay, DS; Sundermann, CA; Tidwell, RR | 1 |
| Arrowood, MJ; Belenkaya, Y; Fallon, MT; Mead, JR; Pharr, JE; Schinazi, RF; You, X | 1 |
2 other study(ies) available for alborixin and maduramicin
| Article | Year |
|---|---|
Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines.
Topics: 4-Quinolones; Amidines; Animals; Animals, Suckling; Anti-Bacterial Agents; Anti-Infective Agents; Cryptosporidium; Enrofloxacin; Ethers; Fluoroquinolones; Ionophores; Lactones; Mice; Mice, Inbred ICR; Pentamidine; Pyrans; Quinolones | 1991 |
Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosis.
Topics: Animals; Anti-Bacterial Agents; Chronic Disease; Cryptosporidiosis; Female; Lactones; Mice; Mice, SCID; Pyrans; Weight Loss | 1995 |